Modeling of neuroleptics with and without EPS side effects

Chinese Pharmaceutical Journal

Volumn 48, Issue 5, 1996, Pages 387-396

  Lien, Eric J ^a   Das, Arima ^a   Lien, Linda L ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

antipsychotics; atypical neuroleptics; dipole moment; extrapyramidal syndrome (EPS); interplanar angle; molecular modeling; neuroleptics

Indexed keywords

AMPEROZIDE; CLOZAPINE; ILOPERIDONE; N (2 CHLORO 6 METHYLERGOLIN 8ALPHA YL)PIVALAMIDE; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PRAMIPEXOLE; QUETIAPINE; SERTINDOLE; ZIPRASIDONE;

ADVERSE DRUG REACTION; AKATHISIA; ARTICLE; DRUG STRUCTURE; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PARKINSONISM; TARDIVE DYSKINESIA;

EID: 0030438278     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lien, E. J.; Gudauskas, G. A. Structure Side-effect Sorting of Drugs I: Extrapyramidal Syndrome. J. Pharm. Sci. 1973, 62, 645-647.
2. Lien, E. J. Adverse Reactions and Chemical Structure, in Drug Design and Adverse Reactions, Alfred Benzon Symposium X: Drug Design and Adverse Reactions, Bundgaard, H.; Juul, J.; Kofod, H. Eds.; Munksgaard: Copenhagen, 1976; pp 233-245.
3. Lien, E. J. SAR, Side Effects and Drug Design; Marcel Dekker, Inc: New York and Basel, 1987; pp 188-191.
4. De Maio, D. Clozapine a Novel Major Tranquilizer. Arneimittel-Forsch 1972, 22, 919-923.
5. Kane, J. M.; Honigfeld, G.; Singer, J.; Meltzer, H. Clozapine in Treatment-resistant Schizophrenics. Psychopharmacol Bull. 1988, 24, 62-67.
6. Davis, R. S.; Kahn, G. K.; Davidson, M. Dopamine in Schizophrenia: a Review and Reconceptualization. Am. J. Psychiatry 1991, 148, 1474-1486.
7. Hirsch, S. R.; Weinberger, D. R. Schizophrenia; Blackwell Science, 1995.
8. Largent, B. L.; Wiksröm, H.; Snowman, A. M.; Snyder, S. H. Novel Antipsychotic Drugs Share High Affinity for Receptors. Europ. J. Pharmacol. 1988, 55, 345-347.
9. Grind, M.; Nilsson, M. L; Nilsson, L.; Oxenstierna, G.; Sedvall, G.; Wahlen, A. Remoxipride - A New Potential Antipsychotic Compound. Tolerability and Pharmacokinetics After Single Oral and Intravenous Administration in Healthy Male Volunteers. Psycopharmacology 1989, 98, 304-309.
10. HyperChem® for Windows. Hypercube Inc. Publication MC40-00-02-01, 419 Phillip St. Waterloo, Ontario, Canada, 1994.
11. Simpson, G. M.; Pi, E. H.; Sramek, Jr. J. J. Neuroleptics and Antipsychotics. in Meyler's Side effects of Drugs, 12th ed.; Dukes, M. N. G. Ed.; Elsovier, New York, N. Y. 1992, pp 105-121.
12. Levine, V. A.; Naffziger, M. C. Laboratories for Neurosurgical Research, UCSF (Private Communication) 1973.
13. Simpson, G. M. Department of Psychiatry and the Behavioral Sciences, USC School of Medicine (Private Communication) 1996.
14. Lien, E. J. Chapter 13. Molecular Structure, Properties and States of Matter, in Remington: The Science and Practice of Pharmacy, 19th ed.; Gennaro, A. R. Ed.; Mack Publishing Company: Easton, Pennsylvania, 1995; pp 147-168.
15. Simpson, G. M.; Pi, E. H.; Sranek, Jr. J. J. Management of Tardive Dyskinesia: Current Update Drugs, 1982, 23, 381-393.